Review Article
Medication Exposures and Subsequent Development of Ewing Sarcoma: A Review of FDA Adverse Event Reports
Table 2
Characteristics of 25 FDA case reports of pre-ESFT drug exposures.
| | Age/sex | Disease | latency | Site | Drug | Type | Concomitant meds | Other |
| 1 |
13 f | Crohn’s | >2 yrs | Pelvis | Infliximab | Immune | None reported | | 2 | 26 f | Crohn’s | 4 yrs | Calf | Infliximab | Immune | Mesalamine, GH | Severe Crohn’s, registry azathioprine lansoprazole | 3 | 39 m | Crohn’s |
2.5 yrs | Unknown | Infliximab | Immune | Mesalamine, Azathioprine | | 4 | f | MS | 9-10 mos | Clavicle | Interferon | Immune | Potassium | pmh: clavicle fibrodysplasia, beta-1A, FMH positive for cancer | 5 | 68 f | MS | >5 yrs | Shoulder | Interferon | Immune | No information | beta-1A | 6 | 54 f | MS | 3 mos | Brain | Natalizumab | immune | No information | | 7 | m | Ankylosing spondylitis | unknown | Unknown | Infliximab | Immune | No information | | 8 | 50 f | RA | 4 yrs | Unknown | Etanercept | Immune | No information | Canada | | | | | | | | | | 9 | 20 m | Psoriasis | 6 yrs | Unknown | Infliximab | Immune | Methotrexate, cyclosporine, etanercept | Acitretin, efalizumab >6 yrs | 10 | 52 m | transplant | 8 yrs | Abdomen | Cyclosporine | Immune | steroids, azathioprine | Lliterature case [18] patient had OKT3 ab 2 transplants, nephrosclerosis | | | | | | | | | | 11 | 65 m | Chronic hepatitis C | 12 yrs | Unknown | Peginterferon | Immune | | Cholecystectomy, cirrhosis, esophageal varices alfa-2b and ribavirin | 12 | 5 f | Nephrotic sx | 18 mos | Spine | Cyclosporine | Immune | Dipyramidole, warfarin, prednisolone, cyclosporin | | 13 | 11 f | GH def | 18 mos | Thigh | r-somatropin | Hormone | | Dose 0.7 mg sq should have been 0.47 | 14 | 16 f | GH def | Unknown | Clavicle | r-somatropin | Hormone | | Patient grew 2.5 cm after GH | 15 | 47 f | Menopause | 10 mos | Spine | Estrogen/progestin | hormone | No information | Medical history—negative | 16 | 24 f | Contraception | 2.5 yrs | Unknown | Etonogestrel | Hormone | No information | Patient wt 268 lbs, ht 66.9′′, BMI = 42 | 17 | 49 f | Osteoporosis | 4 mos | Shoulder | Teriparatide | Hormone | | Other osteoporosis drugs, family history—breast cancer | 18 | 17 m | Unspecified psychiatric condition | unknown | Unknown | Olanzapine | Psychotropic | Acetaminophen | |
19 | 19 m | Depression | 3 mos | Unknown | Olanzapine | Psychotropic | Clonazepam | Unspecified depression | 20 | 8 m | Epilepsy | 8 yrs | metastatic | Ethosuximide | Psychotropic | Clobazam, valproic acid | CNS depressant | 21 | 8 f | ADHD | Unknown | Mnknown | Methylphenidate | Psychotropic | | | 22 | 34 f | Narcolepsy | 22 mos | Unknown | Sodium oxybate | Psychotropic | None | | 23 | 42 f | Sciatica | Unknown | Unknown | Pregabalin | Psychotropic | Lisinopril for high blood pressure | Fibromyalgia, CNS depressant peripheral neuropathy | 24 | 24 f | Acne | 10 mos | Unknown | Isotretinoin | Others | No information | | 25 | 9 m | High cholesterol | 23 mos | Mandible | Atorvastatin | Cholesterol Lowering | Ezetimibe | 3-year trial |
|
|